UK will no longer prescribe puberty blockers to children — RT World News
Controversial drugs are known to cause irreversible side effects in 'transgender' children.
Britain's National Health Service (NHS) announced on Tuesday that it will stop offering puberty-blocking drugs to children at so-called “gender identity” clinics. The Conservative government in the United Kingdom welcomed the decision “A historic decision.”
The decision was reported by several British media outlets and follows a public consultation and four-year investigation into the activities of the NHS Gender Identity Development Service (GIDS), which is run by the Tavistock and Portman NHS Foundation Trust in London.
It was the Tavistock Clinic Command To be closed in 2022 after investigators concluded that its doctors were “Haste” Children – some as young as seven years old – undergo experimental and life-changing sex reassignment procedures.
Puberty blocking medications prevent the body from undergoing the typical physical changes that occur during puberty. In boys, it limits the growth of the penis and testicles and prevents the growth of facial hair. In girls, they slow breast growth and prevent menstruation. Patients taking puberty blockers often follow this treatment with cross-sex hormone therapy in an attempt to change their gender.
While advocates of these medications maintain that the changes are reversible, puberty blockers have been linked to them Osteoporosis And Deformed genitals In patients, sometimes long after treatment has stopped. A court ruling in 2020 banned the prescription of these drugs to children under 16, but the ruling was overturned in another ruling the following year.
Health Minister Maria Caulfield said governments welcomed Tuesday's decision “Historic decision” In addition to that “Ending routine prescriptions for puberty blockers will help ensure that care is based on evidence and expert clinical opinion and is in the best interests of the child.”
Following the NHS announcement, puberty blockers will only be given to children as part of clinical trials.
Although the Tavistock clinic is due to close, the NHS is opening two new GIDS clinics in April, one in London and the other in Liverpool. Around 250 patients will be transferred from the Tavistock clinic to the new facilities once they open.
The number of children referred to GIDS has risen significantly in recent years. Only 100 children were treated in GIDS centers in the period 2009-2010, a number that increased to 5,000 in the period 2021-2022.
You can share this story on social media:
Source link
